Xylem (NYSE:XYL) Falls on Q3 Revenue Miss and Cut to Full-Year 2026 Outlook
Xylem Q3 2026 revenue missed estimates, EPS was in line; lower full-year guidance and sales shortfall sent shares down sharply premarket.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: ChartMill